One explanation may be the fact that most research has focused on the identification of tumor antigens recognized by MHC class I (MHC-I)-restricted CD8+ T cells, and many tumor antigens recognized by CD8+ T cells have proven to be poorly immunogenic. Here, CD8A is linked to neoplasm.